E-Cigarettes Are 'Gateway Drugs': Researchers

Thursday, 04 Sep 2014 12:17 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Like conventional cigarettes, electronic cigarettes may function as a "gateway drug" that can prime the brain to be more receptive to harder drugs, U.S. researchers said on Wednesday.
The findings, published in the New England Journal of Medicine, add to the debate about the risks and benefits of electronic cigarettes, the increasingly popular devices that deliver nicotine directly without burning tobacco.
"With e-cigarettes, we get rid of the danger to the lungs and to the heart, but no one has mentioned the brain," coauthor Dr. Eric Kandel of Columbia University, whose findings were published in the New England Journal of Medicine, said in a telephone interview.
In laboratory studies, the researchers showed that "once mice and rats are on nicotine, they are more addicted to cocaine" after being introduced to that drug, said Dr. Aruni Bhatnagar of the University of Louisville, who was not involved in the study but chaired a 10-member American Heart Association panel on the impact of e-cigarettes.
That was true even when the mice received nicotine without burning tobacco, Kandel, a 2000 Nobel laureate for his work on memory, told Reuters Health in a telephone interview.
The findings by Kandel and his wife, Columbia University researcher Denise Kandel, expand on her earlier work on nicotine as a "gateway drug," a theory she first reported on in 1975.
"E-cigarettes have the same physiological effects on the brain and may pose the same risk of addiction to other drugs as regular cigarettes, especially in adolescence during a critical period of brain development," they wrote.
Although it is not yet clear whether e-cigarettes will prove to be a gateway to the use of conventional cigarettes and illicit drugs, they said "that's certainly a possibility."
"Nicotine clearly acts as a gateway drug on the brain, and this effect is likely to occur whether the exposure comes from smoking cigarettes, passive tobacco smoke, or e-cigarettes," they wrote.
Electronic cigarettes are now a $3 billion business with 466 brands that include candy flavoring and are increasingly popular among children, according to the World Health Organization.
Using 2004 epidemiologic data from a large, longitudinal sample, Denise Kandel found that the rate of cocaine dependence was highest among users who started using cocaine after having smoked cigarettes.
Dr. Shanta Rishi Dube of the Georgia State University School of Public Health, who was not involved in the research, said the results "appear valid based on prior studies that have looked at nicotine as a potential gateway (drug)."
Bhatnagar said the findings strengthen the case for regulation of e-cigarettes by the U.S. Food and Drug Administration.
"If we don't have strict laws on youth access and marketing for e-cigarettes, we may fuel an entire new generation of people on nicotine, and that will be a gateway drug for the use of other drugs," Bhatnagar said.
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

The Sinister Secret of CoQ10 and Statin Drugs

Tuesday, 21 Oct 2014 11:16 AM

SPECIAL: Do you know how most CoQ10 is made? Learn the shocking truth you won’t find on the label. . . .

Lung Patients Often Buy Cigarettes Along With Meds

Tuesday, 21 Oct 2014 08:24 AM

While picking up a prescription for cholesterol-lowering medication,about one in 20 people with conditions such as asthm . . .

New Weight Loss Drug Saxenda Headed for FDA Approval

Tuesday, 21 Oct 2014 08:18 AM

The U.S. Food and Drug Administration is likely to approve Novo Nordisk's new drug to treat obesity this year, analysts  . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved